Total Payments
$446,138
2024 Payments
$56,916
Companies
41
Transactions
719
Medicare Patients
1,804
Medicare Billing
$317,203
Payment Breakdown by Category
Other$326,061 (73.1%)
Travel$67,098 (15.0%)
Consulting$32,293 (7.2%)
Food & Beverage$18,019 (4.0%)
Education$2,668 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $288,140 | 110 | 64.6% |
| Travel and Lodging | $67,098 | 151 | 15.0% |
| Honoraria | $37,921 | 14 | 8.5% |
| Consulting Fee | $32,293 | 10 | 7.2% |
| Food and Beverage | $18,019 | 361 | 4.0% |
| Education | $2,668 | 73 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $201,560 | 325 | $0 (2024) |
| Genentech USA, Inc. | $115,095 | 107 | $0 (2024) |
| Janssen Biotech, Inc. | $68,242 | 84 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $48,461 | 55 | $0 (2021) |
| Eisai Inc. | $8,458 | 13 | $0 (2024) |
| Abbott Laboratories | $722.66 | 6 | $0 (2024) |
| GENZYME CORPORATION | $614.53 | 6 | $0 (2023) |
| PFIZER INC. | $495.93 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $294.56 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $249.99 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,916 | 54 | Alexion Pharmaceuticals, Inc. ($43,052) |
| 2023 | $50,062 | 51 | Genentech USA, Inc. ($37,736) |
| 2022 | $69,887 | 53 | Genentech USA, Inc. ($30,369) |
| 2021 | $36,579 | 46 | Janssen Biotech, Inc. ($17,719) |
| 2020 | $35,296 | 49 | Janssen Biotech, Inc. ($21,399) |
| 2019 | $81,120 | 103 | Alexion Pharmaceuticals, Inc. ($32,725) |
| 2018 | $65,151 | 137 | Alexion Pharmaceuticals, Inc. ($46,004) |
| 2017 | $51,127 | 226 | Alexion Pharmaceuticals, Inc. ($46,018) |
All Payment Transactions
719 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Genentech USA, Inc. | Columvi (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,520.00 | General |
| Category: BioOncology | ||||||
| 11/09/2024 | Genentech USA, Inc. | Columvi (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: BioOncology | ||||||
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,610.00 | General |
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $497.98 | General |
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $169.35 | General |
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $84.99 | General |
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $64.98 | General |
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $527.98 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $456.86 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $135.00 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $51.74 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $13.74 | General |
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.41 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,440.00 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.60 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $70.65 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $52.39 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $38.00 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $25.78 | General |
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $6.30 | General |
| 09/26/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $727.45 | General |
| 09/26/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $453.00 | General |
| 09/26/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $70.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 523 | 1,201 | $307,671 | $92,976 |
| 2022 | 5 | 508 | 1,182 | $310,139 | $94,537 |
| 2021 | 4 | 424 | 983 | $247,189 | $77,924 |
| 2020 | 8 | 349 | 829 | $205,589 | $51,767 |
Total Patients
1,804
Total Services
4,195
Medicare Billing
$317,203
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 282 | 795 | $182,395 | $54,923 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 99 | 240 | $77,760 | $25,063 | 32.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 52 | 52 | $25,606 | $6,931 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 68 | 92 | $13,616 | $4,018 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $8,294 | $2,040 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 250 | 746 | $170,834 | $51,073 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 127 | 281 | $90,763 | $29,762 | 32.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 66 | 66 | $32,406 | $8,986 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 48 | 70 | $10,360 | $3,240 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 19 | $5,776 | $1,475 | 25.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 184 | 564 | $129,156 | $40,634 | 31.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 108 | 228 | $73,644 | $24,908 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 85 | 144 | $21,312 | $6,607 | 31.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 47 | 47 | $23,077 | $5,775 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 111 | 493 | $113,033 | $28,457 | 25.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 45 | 45 | $22,095 | $5,290 | 23.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 67 | 135 | $20,012 | $5,029 | 25.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 36 | 56 | $18,088 | $4,665 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 34 | $13,532 | $3,699 | 27.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 23 | 23 | $8,671 | $1,924 | 22.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 31 | $6,510 | $1,723 | 26.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 12 | $3,648 | $979.50 | 26.9% |
About Khuda Khan, M.D., PH.D
Khuda Khan, M.D., PH.D is a Hematology & Oncology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619946159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Khuda Khan, M.D., PH.D has received a total of $446,138 in payments from pharmaceutical and medical device companies, with $56,916 received in 2024. These payments were reported across 719 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($288,140).
As a Medicare-enrolled provider, Khan has provided services to 1,804 Medicare beneficiaries, totaling 4,195 services with total Medicare billing of $317,203. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Louisville, KY
- Active Since 03/16/2006
- Last Updated 10/23/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1619946159
Products in Payments
- SOLIRIS (Drug) $81,811
- DARZALEX (Biological) $66,740
- VENCLEXTA (Biological) $41,406
- TASIGNA (Drug) $25,690
- Lunsumio (Biological) $22,330
- ULTOMIRIS (Biological) $21,580
- Rituxan (Biological) $19,087
- GLEEVEC (Drug) $15,830
- Venclexta (Biological) $14,892
- Polivy (Biological) $9,881
- Lenvima (Drug) $8,335
- Ultomiris (Drug) $8,052
- Columvi (Biological) $4,181
- Alecensa (Biological) $3,202
- TECVAYLI (Biological) $1,100
- CABLIVI (Biological) $341.75
- ULTOMIRIS (Drug) $269.23
- ELIQUIS (Drug) $242.76
- ERLEADA (Drug) $208.85
- KEYTRUDA (Biological) $182.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Louisville
Goetz Kloecker, Md, MD
Hematology & Oncology — Payments: $761,985
Hematology & Oncology $761,985
Vivek Sharma, Md, MD
Hematology & Oncology — Payments: $594,741
Hematology & Oncology $594,741
Dr. Jeffrey Hargis, M.d, M.D
Hematology & Oncology — Payments: $430,805
Hematology & Oncology $430,805
Dr. Joseph Maly, M.d, M.D
Hematology & Oncology — Payments: $43,035
Hematology & Oncology $43,035
Dr. Emmanuel Nidhiry, M.d, M.D
Hematology & Oncology — Payments: $40,629
Hematology & Oncology $40,629
Dharamvir Jain, Md, MD
Hematology & Oncology — Payments: $26,287
Hematology & Oncology $26,287